These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11101737)

  • 1. High incidence of adriamycin cardiotoxicity in children even at low cumulative doses: role of radionuclide cardiac angiography.
    Agarwala S; Kumar R; Bhatnagar V; Bajpai M; Gupta DK; Mitra DK
    J Pediatr Surg; 2000 Dec; 35(12):1786-9. PubMed ID: 11101737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing adriamycin-induced early cardiotoxicity by estimating left ventricular ejection fraction using technetium-99m multiple-gated acquisition scan and echocardiography.
    Fatima N; Zaman MU; Hashmi A; Kamal S; Hameed A
    Nucl Med Commun; 2011 May; 32(5):381-5. PubMed ID: 21346663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxorubicin cardiotoxicity: prevention of congestive heart failure with serial cardiac function monitoring with equilibrium radionuclide angiocardiography in the current era.
    Mitani I; Jain D; Joska TM; Burtness B; Zaret BL
    J Nucl Cardiol; 2003; 10(2):132-9. PubMed ID: 12673177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuing routine cardiac surveillance in long-term use of pegylated liposomal doxorubicin: is it necessary?
    Gill SE; Savage K; Wysham WZ; Blackhurst DW; Winter WE; Puls LE
    Gynecol Oncol; 2013 Jun; 129(3):544-7. PubMed ID: 23523653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinoma.
    Harris L; Batist G; Belt R; Rovira D; Navari R; Azarnia N; Welles L; Winer E;
    Cancer; 2002 Jan; 94(1):25-36. PubMed ID: 11815957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and economic impact of multiple gated acquisition scan monitoring during anthracycline therapy.
    Shureiqi I; Cantor SB; Lippman SM; Brenner DE; Chernew ME; Fendrick AM
    Br J Cancer; 2002 Jan; 86(2):226-32. PubMed ID: 11870511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adriamycin cardiotoxicity in children: case reports, literature review, and risk factors.
    Prout MN; Richards MJ; Chung KJ; Joo P; Davis HL
    Cancer; 1977 Jan; 39(1):62-5. PubMed ID: 188540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.
    Swain SM; Whaley FS; Ewer MS
    Cancer; 2003 Jun; 97(11):2869-79. PubMed ID: 12767102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2.
    Safra T; Muggia F; Jeffers S; Tsao-Wei DD; Groshen S; Lyass O; Henderson R; Berry G; Gabizon A
    Ann Oncol; 2000 Aug; 11(8):1029-33. PubMed ID: 11038041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies.
    Carrió I; Lopez-Pousa A; Estorch M; Duncker D; Berná L; Torres G; de Andrés L
    J Nucl Med; 1993 Sep; 34(9):1503-7. PubMed ID: 8355070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radionuclide Methods in the Assessment of Anthracycline-Induced Cardiotoxicity].
    Chernov VI; Kravchuk TL; Zelchan RV; Goldberg VE
    Kardiologiia; 2015; 55(7):57-62. PubMed ID: 26688927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congestive heart failure due to adriamycin cardiotoxicity: its natural history in children.
    Goorin AM; Borow KM; Goldman A; Williams RG; Henderson IC; Sallan SE; Cohen H; Jaffe N
    Cancer; 1981 Jun; 47(12):2810-6. PubMed ID: 6942908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive monitoring of adriamycin cardiotoxicity by "Sphygmo-Recording" of the pulse wave delay (QKd interval).
    Greco FA; Brereton HD; Rodbard D
    Cancer Treat Rep; 1976 Sep; 60(9):1239-45. PubMed ID: 797446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of noninvasive cardiac parameters in the detection and evaluation of adriamycin cardiotoxicity.
    Shuman RD; Ettinger DS; Abeloff MD; Livengood SV; Fortuin NJ
    Johns Hopkins Med J; 1981 Aug; 149(2):57-63. PubMed ID: 7253365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adriamycin (doxorubicin) cardiotoxicity: a review.
    Chlebowski RT
    West J Med; 1979 Nov; 131(5):364-8. PubMed ID: 394479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is MUGA scan necessary in patients with low-risk breast cancer before doxorubicin-based adjuvant therapy? Multiple gated acquisition.
    Sabel MS; Levine EG; Hurd T; Schwartz GN; Zielinski R; Hohn D; Edge SB
    Am J Clin Oncol; 2001 Aug; 24(4):425-8. PubMed ID: 11474280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac safety profile of prolonged (>or=6 cycles) pegylated liposomal doxorubicin administration in patients with gynecologic malignancies.
    Uyar D; Kulp B; Peterson G; Zanotti K; Markman M; Belinson J
    Gynecol Oncol; 2004 Jul; 94(1):147-51. PubMed ID: 15262133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.
    Cardinale D; Colombo A; Bacchiani G; Tedeschi I; Meroni CA; Veglia F; Civelli M; Lamantia G; Colombo N; Curigliano G; Fiorentini C; Cipolla CM
    Circulation; 2015 Jun; 131(22):1981-8. PubMed ID: 25948538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography.
    Alexander J; Dainiak N; Berger HJ; Goldman L; Johnstone D; Reduto L; Duffy T; Schwartz P; Gottschalk A; Zaret BL
    N Engl J Med; 1979 Feb; 300(6):278-83. PubMed ID: 759880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group.
    Green DM; Grigoriev YA; Nan B; Takashima JR; Norkool PA; D'Angio GJ; Breslow NE
    J Clin Oncol; 2001 Apr; 19(7):1926-34. PubMed ID: 11283124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.